UnitedHealth Group (UNH) Projected to Post Quarterly Earnings on Thursday

UnitedHealth Group (NYSE:UNH) will likely be issuing its quarterly earnings data before the market opens on Thursday, April 17th. Analysts expect the company to announce earnings of $7.24 per share and revenue of $111.56 billion for the quarter. UnitedHealth Group has set its FY25 guidance at $29.50-30.00 EPS.Parties interested in participating in the company’s conference call can do so using this link.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. During the same quarter in the prior year, the firm earned $5.83 earnings per share. The firm’s revenue was up 6.8% on a year-over-year basis. On average, analysts expect UnitedHealth Group to post $30 EPS for the current fiscal year and $33 EPS for the next fiscal year.

UnitedHealth Group Price Performance

UNH opened at $586.23 on Tuesday. The stock has a market capitalization of $536.23 billion, a P/E ratio of 37.82, a PEG ratio of 1.37 and a beta of 0.61. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group has a 12-month low of $438.50 and a 12-month high of $630.73. The stock has a 50-day moving average price of $513.80 and a 200-day moving average price of $541.83.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.43%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s payout ratio is currently 54.19%.

Analyst Ratings Changes

Several equities analysts recently commented on the stock. Barclays reduced their target price on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a report on Friday, January 17th. Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target on the stock in a research report on Friday, January 10th. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Finally, Mizuho upped their price target on shares of UnitedHealth Group from $600.00 to $650.00 and gave the company an “outperform” rating in a report on Wednesday, April 9th. Twenty-one research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Buy” and an average price target of $632.85.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of the stock in a transaction that occurred on Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. The trade was a 28.57 % increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 0.33% of the company’s stock.

Hedge Funds Weigh In On UnitedHealth Group

A hedge fund recently raised its stake in UnitedHealth Group stock. Revolve Wealth Partners LLC lifted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 137.1% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,019 shares of the healthcare conglomerate’s stock after purchasing an additional 2,324 shares during the quarter. Revolve Wealth Partners LLC’s holdings in UnitedHealth Group were worth $2,033,000 as of its most recent SEC filing. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.